Vaxcyte, Inc.
Vaxcyte, Inc. scores highest on Nitro (71) and lowest on Price (18). Its PosiPenta is 42.70 out of 100, around the middle of similar companies.
On the Penta Grid this week, Vaxcyte, Inc. is Grid #444 of 836 in the Healthcare sector in United States, and Grid #2,619 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | 42.70 | 18 | 19 | 71 | 59 | 47 |
| Henry Schein, Inc. | 64.98 | 47 | 79 | 93 | 52 | 54 |
| Oscar Health, Inc. | 65.04 | 41 | 76 | 93 | 68 | 48 |
| Krystal Biotech, Inc. | 64.56 | 22 | 62 | 83 | 84 | 71 |
| 10x Genomics, Inc. | 51.48 | 6 | 71 | 75 | 61 | 44 |
| Bio-Rad Laboratories, Inc. | 74.33 | 45 | 95 | 99 | 61 | 72 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -8.35 |
| P/B ratio | 3.63 |
EEarnings
| Trailing EPS | ₹-721.73 |
| Forward EPS | ₹-669.36 |
NNitro
| Price | 6025.77 |
| 52-week high | 8595.38 |
| 52-week low | 3776.29 |
| Fall from 52-week high | 29.9% |
TTorque
| Return on equity (ROE) | -36.51% |
| Debt-to-equity | 0.04 |
AAnchor
| Beta (price swings) | 1.23 |
| Market cap | ₹94,839 Cr |
| Insider holding | 0.49% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Vaxcyte, Inc.'s PosiPenta score?
Vaxcyte, Inc.'s PosiPenta is 42.70 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Vaxcyte, Inc. stand on the Penta Grid?
On the Penta Grid this week, Vaxcyte, Inc. is Grid #444 of 836 in the Healthcare sector in United States, and Grid #2,619 of 3,999 in United States.
Which PosiPenta pillar is strongest for Vaxcyte, Inc.?
Nitro (momentum), with a score of 71 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Vaxcyte, Inc.?
Price (valuation), with a score of 18 out of 100: much weaker than most similar companies.
Has Vaxcyte, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.58 points, from 41.12 to 42.70.
PositoAI is for research and education only and is not investment advice.